课题基金 / 基金详情

STUDY OF TELOMERASE ACTIVITY AND EXPRESSION OF THE CATALYTIC SUBUNIT ASSOCIATED WITH THIS GENE IN HUMAN UROLOGICAL CANCER.

STUDY OF TELOMERASE ACTIVITY AND EXPRESSION OF THE CATALYTIC SUBUNIT ASSOCIATED WITH THIS GENE IN HUMAN UROLOGICAL CANCER.
研究人类泌尿癌中端粒酶活性和与该基因相关的催化亚基的表达。
批准号:
09671645
负责人:
FUJIOKA Tomoaki
金额:
$1.86万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

FUJIOKA Tomoaki的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Teromerase is the ribonucleoprotein enzyme associated with the immortalization and oncogenesis of cancer cells. Telomerase activity was examined in 47 RCCs using PCR-based telomeric repeat amplification protocol (TRAP) assay. Among 30 RCCs, 18 samples(60%) displayed the activity, white none of the normal tissues exhibited the activity. Subdivision of the tumors according to telomerase activity did not reveal any obvious difference in distribitution of tumor size, stage, histocytological subtype, or DNA-ploidy. However, statistically significant relationship between the frequency of telomerase-positive activity and serum lAP levels or tumor grade was foumd, respectively (p<0.05). These results indicate that telomerase activity may be an important factor for' evaluating the malignancy potential of RCC, rather than for detecting malignancy of the kidney.Although TRAP assay is a highly sensitivity method, it has been reported that Taq inhibitor and other factors in method might cause false results during PCR amplification. Recently, three new major components of telomerase genes which are hTR, TLP1/TPI, and hEST2/hTRT has been cloned. In 27 human urinary bladder cancers, expression of hEST2/hTRT and TLP1/TPI was studied by using revel-se transcriptase-polymerase chain reaction (RT-PCR) method. In all 27 cancers (100%), hEST2/hTRT expression was detected, while TLP1/TPL was displayed in 25 of 27 speciniens(92%). Five normal bladder tissues showed no expression of hEST2/hTRT, but 3 of 5 tisses (60%) did TLPl/TP1 expression. These results indicated that RT-PCR for detecting expression of hEST2/hTRP gene may be a powerful method for the mass screening or diagnosis of urinary bladder.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tumor-specific vaccine therapy using the epitope peptide derived from a tumor antigen gene for the upper urinary tract cancer
  • 批准号:
    20591864
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.0万
  • 财政年份:
    2008
  • 负责人:
    FUJIOKA Tomoaki
  • 依托单位:
Development of the prediction system for chemosensitivity of Methotrexate, Vinblastine, Doxorubicin, and Cisplatin neoadjuvant chemotherapy in invasive bladder cancer patients
  • 批准号:
    18591769
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.55万
  • 财政年份:
    2006
  • 负责人:
    FUJIOKA Tomoaki
  • 依托单位:
Tumor growth inhibition and cancer prevention by serene enriched garlic in murine renal adenocarcinoma
  • 批准号:
    13671672
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.24万
  • 财政年份:
    2001
  • 负责人:
    FUJIOKA Tomoaki
  • 依托单位:
TUMOR REGRESSION CAUSED BY ACTIVATED VITAMIN D_3 IN MURINE RENAL CARCINOMA.
  • 批准号:
    05671331
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 资助金额:
    $1.34万
  • 财政年份:
    1993
  • 负责人:
    FUJIOKA Tomoaki
  • 依托单位: